[HTML] mdpi.com

[HTML][HTML] Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios

F Lucà, F Oliva, MG Abrignani, SA Di Fusco… - Journal of Clinical …, 2023 - mdpi.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
被引用次数：10 相关文章

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, MG Abrignani… - Journal of Clinical …, 2023 - cris.maastrichtuniversity.nl
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, MG Abrignani… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, MG Abrignani… - Journal of Clinical …, 2023 - search.proquest.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, M Abrignani, S Di Fusco… - Journal of Clinical …, 2023 - europepmc.org
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios.

F Lucà, F Oliva, MG Abrignani, SA Di Fusco… - Journal of Clinical …, 2023 - go.gale.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
[HTML] nih.gov

[HTML][HTML] Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, MG Abrignani… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
[PDF] academia.edu

[PDF][PDF] Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Lucà, F Oliva, MG Abrignani, SA Di Fusco, I Parrini… - J. Clin. Med, 2023 - academia.edu
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

F Luca, F Oliva, M Abrignani, S Di Fusco… - JOURNAL OF …, 2023 - boa.unimib.it
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios.

F Lucà, F Oliva, MG Abrignani… - Journal of Clinical …, 2023 - search.ebscohost.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …